- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.87 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 8 x 6DR: 6-ethyl-5-{3-[2-methoxy-5-(pyridin-4-yl)phenyl]prop-1-yn-1-yl}pyrimidine-2,4-diamine(Non-covalent)(Covalent)
6DR.2: 15 residues within 4Å:- Chain A: M.6, V.7, A.8, P.19, I.21, E.28, Q.29, F.32, S.50, M.51, S.97, Y.103, S.116
- Ligands: NAP.1, 6DR.3
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.21, A:Q.29, A:F.32, A:F.32, A:M.51, A:M.51
- Hydrogen bonds: A:S.97, A:S.116, A:S.116
- Water bridges: A:S.116
- Salt bridges: A:E.28
6DR.3: 16 residues within 4Å:- Chain A: M.6, V.7, A.8, E.28, Q.29, F.32, V.43, T.47, M.51, G.52, Y.59, S.97, Y.103, S.116
- Ligands: NAP.1, 6DR.2
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:Q.29, A:F.32, A:F.32, A:F.32, A:F.32, A:F.32, A:T.47, A:M.51
- Hydrogen bonds: A:M.6, A:Q.29, A:S.116, A:S.116
- Water bridges: A:S.116
- Salt bridges: A:E.28
6DR.7: 17 residues within 4Å:- Chain B: M.6, V.7, A.8, P.19, I.21, E.28, Q.29, F.32, K.33, S.50, M.51, L.54, S.97, Y.103, S.116
- Ligands: NAP.6, 6DR.8
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:I.21, B:F.32, B:F.32, B:M.51, B:M.51
- Hydrogen bonds: B:S.97, B:Y.103, B:S.116, B:S.116
- Water bridges: B:S.116
- Salt bridges: B:E.28
6DR.8: 19 residues within 4Å:- Chain B: M.6, V.7, A.8, I.21, E.28, Q.29, F.32, V.43, T.47, F.48, M.51, G.52, L.54, Y.59, S.97, Y.103, S.116
- Ligands: NAP.6, 6DR.7
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:I.21, B:F.32, B:F.32, B:F.32, B:F.32, B:T.47, B:M.51, B:M.51, B:L.54, B:L.54
- Hydrogen bonds: B:M.6, B:Y.103, B:S.116, B:S.116
- Water bridges: B:S.116
- Salt bridges: B:E.28
6DR.13: 15 residues within 4Å:- Chain C: M.6, V.7, A.8, P.19, I.21, E.28, Q.29, F.32, S.50, M.51, S.97, Y.103, S.116
- Ligands: NAP.12, 6DR.14
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:I.21, C:Q.29, C:F.32, C:F.32, C:M.51, C:M.51
- Hydrogen bonds: C:S.97, C:Y.103, C:S.116, C:S.116
- Water bridges: C:S.116
- Salt bridges: C:E.28
6DR.14: 16 residues within 4Å:- Chain C: M.6, V.7, A.8, E.28, Q.29, F.32, V.43, T.47, M.51, G.52, Y.59, S.97, Y.103, S.116
- Ligands: NAP.12, 6DR.13
15 PLIP interactions:15 interactions with chain C- Hydrophobic interactions: C:Q.29, C:F.32, C:F.32, C:F.32, C:F.32, C:F.32, C:T.47, C:M.51
- Hydrogen bonds: C:M.6, C:Q.29, C:Y.103, C:S.116, C:S.116
- Water bridges: C:S.116
- Salt bridges: C:E.28
6DR.18: 17 residues within 4Å:- Chain D: M.6, V.7, A.8, P.19, I.21, E.28, Q.29, F.32, K.33, S.50, M.51, L.54, S.97, Y.103, S.116
- Ligands: NAP.17, 6DR.19
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:I.21, D:F.32, D:F.32, D:M.51
- Hydrogen bonds: D:S.97, D:S.116, D:S.116
- Water bridges: D:S.116
- Salt bridges: D:E.28
6DR.19: 19 residues within 4Å:- Chain D: M.6, V.7, A.8, I.21, E.28, Q.29, F.32, V.43, T.47, F.48, M.51, G.52, L.54, Y.59, S.97, Y.103, S.116
- Ligands: NAP.17, 6DR.18
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:I.21, D:F.32, D:F.32, D:F.32, D:F.32, D:T.47, D:M.51, D:L.54, D:L.54
- Hydrogen bonds: D:M.6, D:S.116, D:S.116
- Water bridges: D:S.116
- Salt bridges: D:E.28
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 5 residues within 4Å:- Chain A: K.88, K.89, I.90, T.91, D.92
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.88
- Water bridges: A:D.92
GOL.9: 3 residues within 4Å:- Chain B: D.125
- Chain D: K.46
- Ligands: GOL.20
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.125
- Water bridges: B:K.46, B:E.101, B:Y.127
GOL.15: 5 residues within 4Å:- Chain C: K.88, K.89, I.90, T.91, D.92
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.88
GOL.20: 3 residues within 4Å:- Chain B: K.46
- Chain D: D.125
- Ligands: GOL.9
5 PLIP interactions:3 interactions with chain D, 2 interactions with chain B- Hydrogen bonds: D:D.125
- Water bridges: D:K.46, D:Y.127, B:E.101, B:E.101
- 6 x CA: CALCIUM ION(Non-covalent)
CA.5: 4 residues within 4Å:- Chain A: S.79, I.80, K.81
- Ligands: NAP.1
No protein-ligand interaction detected (PLIP)CA.10: 5 residues within 4Å:- Chain B: E.101, K.104
- Chain D: E.101, K.104
- Ligands: CA.21
No protein-ligand interaction detected (PLIP)CA.11: 5 residues within 4Å:- Chain B: K.104, P.129, E.130
- Chain D: S.105
- Ligands: NAP.17
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:S.105
CA.16: 4 residues within 4Å:- Chain C: S.79, I.80, K.81
- Ligands: NAP.12
No protein-ligand interaction detected (PLIP)CA.21: 5 residues within 4Å:- Chain B: E.101, K.104
- Chain D: E.101, K.104
- Ligands: CA.10
No protein-ligand interaction detected (PLIP)CA.22: 5 residues within 4Å:- Chain B: S.105
- Chain D: K.104, P.129, E.130
- Ligands: NAP.6
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:S.105
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lombardo, M.N. et al., Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates. ACS Infect Dis (2016)
- Release Date
- 2016-05-18
- Peptides
- Dehydrofolate reductase type I: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.87 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 8 x 6DR: 6-ethyl-5-{3-[2-methoxy-5-(pyridin-4-yl)phenyl]prop-1-yn-1-yl}pyrimidine-2,4-diamine(Non-covalent)(Covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 6 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lombardo, M.N. et al., Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates. ACS Infect Dis (2016)
- Release Date
- 2016-05-18
- Peptides
- Dehydrofolate reductase type I: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B